Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

OBJECTIVES: To investigate the benefits and risks associated with aspirin treatment in patients with type 2 diabetes and no previous cardiovascular disease (CVD) in clinical practice. DESIGN: Population-based cohort study between 2005 and 2009, mean follow-up 3.9 years. SETTING: Hospital outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekström, Nils, Cederholm, Jan, Zethelius, Björn, Eliasson, Björn, Fhärm, Eva, Rolandsson, Olov, Miftaraj, Mervete, Svensson, Ann-Marie, Gudbjörnsdottir, Soffia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641436/
https://www.ncbi.nlm.nih.gov/pubmed/23604419
http://dx.doi.org/10.1136/bmjopen-2013-002688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641436/
https://www.ncbi.nlm.nih.gov/pubmed/23604419
http://dx.doi.org/10.1136/bmjopen-2013-002688

Ejemplares similares